ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
Price:
2 267 JPY
-1.18%
Market Closed
Updated:
May 4, 2024
ASKA Pharmaceutical Holdings Co Ltd
Operating Income
|
ASKA Pharmaceutical Holdings Co Ltd
Operating Income Peer Comparison
Comparables:
4502
4568
4578
4519
4503
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ASKA Pharmaceutical Holdings Co Ltd
TSE:4886
|
Operating Income
¥5.1B
|
CAGR 3-Years
50%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Operating Income
¥464.9B
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
17%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Operating Income
¥188B
|
CAGR 3-Years
37%
|
CAGR 5-Years
19%
|
CAGR 10-Years
5%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Operating Income
¥294.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
32%
|
CAGR 10-Years
3%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Operating Income
¥444.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
29%
|
CAGR 10-Years
19%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Operating Income
¥142B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
3%
|
See Also
What is ASKA Pharmaceutical Holdings Co Ltd's Operating Income?
Operating Income
5.1B
JPY
5.1B
JPY
Based on the financial report for Mar 31, 2023, ASKA Pharmaceutical Holdings Co Ltd's Operating Income amounts to 5.1B JPY.
What is ASKA Pharmaceutical Holdings Co Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
13%
13%
Over the last year, the Operating Income growth was 7%. The average annual Operating Income growth rates for ASKA Pharmaceutical Holdings Co Ltd have been 50% over the past three years , 13% over the past five years .
You don't have any saved screeners yet
